The large-scale production of an artificial influenza virus-like particle vaccine in silkworm pupae

Vaccine. 2015 Jan 1;33(1):117-25. doi: 10.1016/j.vaccine.2014.11.009. Epub 2014 Nov 18.

Abstract

We successfully established a mass production system for an influenza virus-like particle (VLP) vaccine using a synthetic H5 hemagglutinin (HA) gene codon-optimized for the silkworm. A recombinant baculovirus containing the synthetic gene was inoculated into silkworm pupae. Four days after inoculation, the hemagglutination titer in homogenates from infected pupae reached a mean value of 0.8 million hemagglutination units (HAU), approximately 2,000 μg HA protein per pupa, more than 50-fold higher than that produced with an embryonated chicken egg. VLPs ranging from 30 nm to 300 nm in diameter and covered with a large number of spikes were detected in the homogenates. The spikes were approximately 14 nm long, similar to an authentic influenza HA spike. Detailed electron micrographs indicated that the VLP spike density was similar to that of authentic influenza virus particles. The results clearly show that the expression of a single HA gene can efficiently produce VLPs in silkworm pupae. When chickens were immunized with the pupae homogenate, the hemagglutination inhibition titer in their sera reached values of 2,048-8,192 after approximately 1 month. This is the first report demonstrating that a large amount of VLP vaccine could be produced by single synthetic HA gene in silkworm pupae. Our system might be useful for future vaccine development against other viral diseases.

Keywords: Baculovirus; H5N1 influenza virus; Vaccine; Virus-like particle.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Viral / blood
  • Baculoviridae / genetics
  • Baculoviridae / growth & development*
  • Biotechnology / methods*
  • Bombyx*
  • Chickens
  • Hemagglutination Inhibition Tests
  • Hemagglutinin Glycoproteins, Influenza Virus / genetics*
  • Influenza Vaccines / administration & dosage
  • Influenza Vaccines / genetics
  • Influenza Vaccines / immunology
  • Influenza Vaccines / isolation & purification*
  • Microscopy, Electron
  • Orthomyxoviridae / genetics
  • Pupa
  • Recombinant Proteins / genetics
  • Technology, Pharmaceutical / methods*
  • Vaccination / methods
  • Vaccines, Virus-Like Particle / genetics
  • Vaccines, Virus-Like Particle / immunology
  • Vaccines, Virus-Like Particle / isolation & purification*
  • Vaccines, Virus-Like Particle / ultrastructure

Substances

  • Antibodies, Viral
  • Hemagglutinin Glycoproteins, Influenza Virus
  • Influenza Vaccines
  • Recombinant Proteins
  • Vaccines, Virus-Like Particle
  • hemagglutinin, avian influenza A virus